Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Dexmedetomidine and Remifentanil on Postoperative Pain in Obese Patients
IRCT20250331065185N1Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Feb 2026
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of dexmedetomidine and remifentanil in postoperative pain and obesity, sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoint: postoperative pain intensity. Started Feb 2026; status: completed.
02
Drugs
dexmedetomidineremifentanil
03
Conditions
postoperative painobesity
Beyond the preview
Go deeper on IRCT20250331065185N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20250331065185N1.